US Patent Issued to Praxis Precision Medicines on Jan. 20 for "Formulations of T-type calcium channel modulators and methods of use thereof" (American, Australian Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,528,772, issued on Jan. 20, was assigned to Praxis Precision Medicines Inc. (Boston).

"Formulations of T-type calcium channel modulators and methods of use thereof" was invented by Margaret S. Lee (Middleton, Mass.), Sapna Makhija Garad (Malden, Mass.), Randall Wagner (Bend, Ore.) and Preetam Ghogale (Melbourne, Australia).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein, in part, are dosage forms and compositions useful for preventing and/or treating a disease or condition relating to aberrant function of a T-type calcium channel, such as epilepsy and epilepsy syndromes (e.g., absence seizures, juvenile myoclonic epilepsy, or a genetic ep...